Daily11h
GSK Shingrix new prefilled syringe presentation accepted for review by USFDA
GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted for review the regulatory application of ...
Pharmabiz14h
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...
Kepler Capital Keeps Their Hold Rating on GlaxoSmithKline (GSK)
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
The Pharma Letter20h
BRIEF—Prefilled syringe presentation of Shingrix accepted for review by FDA
The US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, GSK’s recombinant zoster vaccine for the prevention of ...